Healthcare

Share

Facebook Twitter Linkedin

Thiogenesis Therapeutics Corp. (TSXV:TTI)

0.66 CAD

0.000 0.000%

Last Updated at: 2024-10-04T18:33:00Z

Risk Disclaimer TTI chart by TradingView

Back to TSXV:TTI

Risk Disclaimer TTI chart by TradingView

Sponsored Reports

Loading...

Previous Close (in CAD)	0.66
Change	0.000 0.000%
52 W H/L (in CAD)	0.900/0.490
EBITDA (in CAD)	--
PE Ratio	--
Volume	11000
Diluted Eps TTM	-0.01

Total Assets (in CAD)	3.431M
Total Liabilities (in CAD)	3.492M
Revenue TTM (in CAD)	--
Cash (in CAD)	--
Market Cap (in CAD)	39.928 M
Revenue Per Share TTM	--
Gross Profit TTM (in CAD)	--

Summary

---

Income Statement

Balance Sheet

Change in Cash

Operating Cash

Thiogenesis Therapeutics Corp.

Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-active therapeutic compounds to treat unmet medical needs. Its lead product candidate under development is TTI-0102, a prodrug consisting of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke, Rett syndrome, and pediatric non-alcoholic fatty liver diseases. The company is headquartered in Toronto, Canada.

4 King Street West, Toronto, ON, Canada, M5H 1B6

https://www.thiogenesis.com

Key Executives

Sr. No.	Name	Title	Year Born
1.	Dr. Patrice P. Rioux M.D., Ph.D.	CEO & Director	1951
2.	Ms. Mary Jo Bagger	Consultant for Clinical Operations	NA
3.	Mr. Brook G. Riggins C.F.A.	CFO, Sec. & Director	1966

Peers

Sector: Healthcare

Industry: Biotechnology

Company	Change (CAD)	Price (CAD)	Trailing PE(x)	Forward PE(x)	Price Sales TTM(x)	Price to Book Value(x)	Enterprise Value to Revenue(x)	Enterprise Value to EBITDA(x)
NGEN NervGen Pharma Corp	-0.020 0.820%	2.44	0.000	0.000	0.000	29.478	0.000	-6.948
ARCH Arch Biopartners Inc	+0.030 1.639%	1.85	0.000	0.000	37.823	0.000	53.055	-28.103
MIR MedMira Inc	0.000 0.000%	0.09	0.000	0.000	170.457	0.000	189.937	-48.737
SBM Sirona Biochem Corp	0.000 0.000%	0.08	0.000	0.000	343.735	41.637	359.744	-13.882

• Income Statement
• Balance Sheet
• Cash Flow

Income Statement

(Currency in CAD)

Breakdown	31-12-2021	31-12-2020	31-12-2019
Income Before Tax	-0.224M	-0.093M	-0.073M
Minority Interest	-	-	-
Net Income	-0.224M	-0.093M	-0.073M
Selling General Administrative	0.225M	0.093M	0.058M
Gross Profit	-	-	-
Reconciled Depreciation	-	-	-
Ebit	-	-	-
Ebitda	-0.224M	-0.093M	-0.073M
Depreciation And Amortization	-	-	-
Operating Income	-0.225M	-0.093M	-0.073M
Other Operating Expenses	-	-	-
Interest Expense	0M	0M	0M
Tax Provision	-	-	-
Interest Income	0M	0M	0M
Net Interest Income	0M	-0M	0M
Income Tax Expense	-	-	-
Total Revenue	0M	0M	0M
Total Operating Expenses	0.225M	0.093M	0.073M
Cost Of Revenue	-	-	-
Total Other Income Expense Net	-	-	-
Net Income From Continuing Ops	-0.224M	-0.093M	-0.073M
Net Income Applicable To Common Shares	-	-	-

Balance Sheet

(Currency in CAD)

Breakdown	31-12-2021	31-12-2020	31-12-2019
Total Assets	3.431M	0.146M	0.292M
Intangible Assets	-	-	-
Other Current Assets	-	-	-
Total Liab	3.492M	0.063M	0.012M
Total Stockholder Equity	-0.061M	0.083M	0.28M
Other Current Liab	-	-	-
Common Stock	-	-	-
Capital Stock	0.302M	0.27M	0.001M
Retained Earnings	-0.453M	-0.229M	-0.327M
Good Will	-	-	-
Other Assets	-	-	-
Cash	-	0.019M	0.184M
Cash And Equivalents	-	-	-
Total Current Liabilities	3.492M	0.063M	0.012M
Current Deferred Revenue	-	-	-
Net Debt	-	0.301M	-
Short Term Debt	-	-	-
Short Long Term Debt	-	0.32M	-
Short Long Term Debt Total	-	-	-
Other Stockholder Equity	-	-	-
Property Plant Equipment	-	-	-
Total Current Assets	3.431M	0.146M	0.292M
Long Term Investments	-	-	-
Short Term Investments	-	-	-
Net Receivables	-	0.001M	0.002M
Long Term Debt	-	-	-
Inventory	-	-	-
Accounts Payable	-	0.029M	0.012M
Accumulated Other Comprehensive Income	-	-	-
Non Currrent Assets Other	-	-	-
Non Current Assets Total	0M	0M	0M
Capital Lease Obligations	-	-	-
Long Term Debt Total	-	-	-

Cash Flow

(Currency in CAD)

Breakdown	31-12-2021	31-12-2020	31-12-2019
Investments	-	-	-
Total Cashflows From Investing Activities	-	-	-
Total Cash From Financing Activities	3.327M	0M	0.353M
Net Income	-0.224M	-0.093M	-0.073M
Change In Cash	3.26M	-0.036M	0.153M
Begin Period Cash Flow	0.146M	0.182M	0.03M
End Period Cash Flow	3.406M	0.146M	0.184M
Total Cash From Operating Activities	-0.067M	-0.036M	-0.2M
Depreciation	-	-	-
Other Cashflows From Investing Activities	-	-	-
Dividends Paid	-	-	-
Change To Inventory	-	-	-
Sale Purchase Of Stock	-	-	-
Other Cashflows From Financing Activities	-	-	-
Capital Expenditures	0M	0M	0M
Change In Working Capital	0.157M	0.057M	-0.126M
Other Non Cash Items	-	0.004M	-
Free Cash Flow	-0.067M	-0.036M	-0.2M

No data found

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

• Top Gainer
• Top Loser